MedTrace Logo

Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation

NCT03888833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278

Last updated 2026-02-03

No results posted yet for this study

Summary

Veno arterial extracorporeal membrane oxygenation (VA ECMO) is used, for cardiogenic shock, refractory cardiac arrest and post cardiotomy cardiac failure. Bleeding is frequent complications during VA ECMO and is associated with increased mortality. The aim of our study was to identify early factors associated with major bleeding in patients supported by VA ECMO

Conditions

  • Extracorporeal Membrane Oxygenation
  • Bleeding
  • Complication

Interventions

DEVICE

ECMO

ECMO installation

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2016-12-31
Completion
2018-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03888833 on ClinicalTrials.gov